Improving brain stimulation technology for better treatment of disorders
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
This study is exploring new brain devices that can help people with movement disorders, epilepsy, and possibly other mental health issues by monitoring and stimulating brain activity, so we can create better treatments that adapt to what the brain needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10906376 on NIH RePORTER |
What this research studies
This research focuses on advancing implantable neurotechnology that can monitor and stimulate brain activity to treat movement disorders, epilepsy, and potentially psychiatric and cognitive disorders. By utilizing devices that can wirelessly stream brain signals, researchers aim to understand brain circuit functions better and develop adaptive therapies that adjust to the brain's needs. The project involves collaboration among four institutions to enhance the capabilities of these devices and ensure they meet regulatory standards for clinical use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from movement disorders, epilepsy, or cognitive and psychiatric conditions who may benefit from advanced neurostimulation therapies.
Not a fit: Patients with non-neurological conditions or those who do not respond to neurostimulation therapies may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for patients with various brain disorders.
How similar studies have performed: Previous research has shown promise in using implantable neurotechnology for brain disorders, indicating a potential for success in this innovative approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Starr, Philip Andrew — University of California, San Francisco
- Study coordinator: Starr, Philip Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.